Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05233059 · ClinicalTrials.gov registry record · NA
FitEx for Endometrial Cancer Survivors
A NA study, sponsored by Carilion Clinic.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT05233059: Completed NA study, sponsored by Carilion Clinic.
NCT05233059 is a NA study that has completed, run by Carilion Clinic. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05233059, a NA study, has completed, sponsored by Carilion Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether a physical activity tracking program called FitEx would be useful to endometrial cancer survivors. Each interested endometrial cancer survivor will recruit 1 to 5 additional friends/family members to participate in the intervention with them, forming a team. Each team will be randomized to FitExEC (control group) that receives FitEx for endometrial cancer survivors, or FitExEC+yoga (experimental group) that receives FitEx for endometrial cancer survivors plus yoga cueing. FitExEC is based on FitEx, a program used to encourage adults to improve their fruit and vegetable intake while increasing their physical activity. FitEx works by having participants join a team with their friends and loved ones, so they can support one another in meeting their goals. In this study, teams of endometrial cancer survivors/support members will receive watches that track how much they walk. Each day, participants record how much exercise, how many fruits, and how many vegetables they've eaten that day for a total of 8 weeks. Participants will be encouraged to attend a virtual session 15 minutes per week that will focus on 1-mile worth of exercise points (all control) or 15 minutes of yoga (all experimental) followed by 15 minutes of support (endometrial cancer survivors only \[control and experimental survivors in different groups\]). Participation in the study lasts roughly 10 weeks, and participants will be followed for 6 months afterward. The investigators think that FitEx may help people with endometrial cancer improve their daily physical activity and slowly improve their health and quality of life. The investigators hypothesize this intervention is feasible and acceptable to Carilion Clinic endometrial cancer survivors.
Primary Outcome
Our primary aims are program adherence, measured as the percentage of participants who complete the 8 week program, and recruitment rate, measured as the percentage of participants who join the study out of the total participants who are approached about the study. These outcomes will be used to assess the feasibility and acceptability of the study among participants who enroll in the study and percentage of participants who complete the program.
Interventions
- BEHAVIORAL FitEx
- BEHAVIORAL Weekly Yoga Sessions
- BEHAVIORAL Weekly Movement Sessions
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2021-07-28 |
| Est. Completion | 2022-05-30 |
| Phase | NA |
What the finished NCT05233059 record still lists
NCT05233059 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 3 interventions - of which FitEx is the first listed.
NCT05233059 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05233059 about?
NCT05233059 is a clinical study titled "FitEx for Endometrial Cancer Survivors". The purpose of this study is to determine whether a physical activity tracking program called FitEx would be useful to endometrial cancer survivors. Each interested endometrial cancer survivor will recruit 1 to 5 additional friends/family members to participate in the intervention with them, forming...
What is the current status of trial NCT05233059?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2021-07-28. Estimated completion is 2022-05-30.
What interventions are being tested in trial NCT05233059?
The interventions under investigation include: FitEx (BEHAVIORAL), Weekly Yoga Sessions (BEHAVIORAL), Weekly Movement Sessions (BEHAVIORAL).
Who is sponsoring clinical trial NCT05233059?
This trial is sponsored by Carilion Clinic, which has 45 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05233059's enrollment target sits among peer trials
20 1768th of 2000 higher than 140 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI